Qlaira®: a 'natural' change of direction
Open Access
- 1 July 2009
- journal article
- Published by BMJ in BMJ Sexual & Reproductive Health
- Vol. 35 (3), 139-142
- https://doi.org/10.1783/147118909788707878
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetateContraception, 2009
- Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studiesContraception, 2008
- Dienogest, a selective progestin, reduces plasma estradiol level through induction of apoptosis of granulosa cells in the ovarian dominant follicle without follicle-stimulating hormone suppression in monkeysJournal of Endocrinological Investigation, 2008
- Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimenContraception, 2007
- Effect of four different oral contraceptives on various sex hormones and serum-binding globulinsContraception, 2003
- Inhibition of skin 5α-reductase by oral contraceptive progestinsin vitroGynecological Endocrinology, 2000
- Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic diseaseThe Lancet, 1995
- New natural oestradiol/cyproterone acetate oral contraceptive for pre-menopausal womenMaturitas, 1988